top of page
Press Releases
In the News
- Jan 31, 2023
Ymmunobio Signs Transfer Ownership Agreement with Nagoya University for NPTXR antibodies
Research indicates that NPTXR may have utility for treatment of gastro-intestinal cancers. Read more here: https://www.prnewswire.com/new...
- Jan 31, 2023
Drug Discovery & Development
Ymmunobio get ownership rights to NPTXR antibodies. Read more here: https://www.drugdiscoverytrends.com/ymmunobio-gets-ownership-rights-t...
- Jan 13, 2023
Fierce Biotech: Appointment of Michel Janicot
Michel Janicot will serve in the newly created position of chief development officer. https://www.fiercebiotech.com/biotech/chutes-ladder...
- Jan 10, 2023
Ymmunobio Appoints Dr. Michel Janicot as Chief Development Officer
Ymmunobio adds to executive team. Read more here: https://www.biopharmadive.com/press-release/20230109-ymmunobio-appoints-dr-michel-janic...
bottom of page